Enghouse Systems Limited (EGHSF) — Earnings Call X-Ray
Our AI read all 33 of EGHSF's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
C
Q1 2025
Calls Analyzed
33
2016–2025
Avg Candor
6.8/9
evasion 3/9
Call-by-call analysis
🔒 Q2 2025 earnings call
2025-06-06
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q2 2025 call grade is ready
The full 37-point AI read of EGHSF's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
C
Q1 2025 earnings call
2025-03-11
move ±10.4%
Management gave no formal guidance against mixed demand signals and contracting margins.
Demand: mixedMargins: contractingPricing: stable 3 analysts · 8 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubts✓ Prepayments growing
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
F
Q4 2024 earnings call
2024-12-13
move ±10.3%
Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was frequently evasive.
Demand: mixedMargins: contractingPricing: under pressureHeadcount: cuttingCapex: flat 3 analysts · 7 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritableFounder-ledHidden segmentDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
A
Q3 2024 earnings call
2024-09-06
move ±12.6%
Management gave no formal guidance against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.
Demand: acceleratingMargins: expandingPricing: stable 3 analysts · 7 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growingFounder-led
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C+
Q2 2024 earnings call
2024-06-11
move ±9.9%
Management gave no formal guidance against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.
Demand: stableMargins: expandingPricing: stable 3 analysts · 8 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubtsFounder-led
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C
Q1 2024 earnings call
2024-03-14
move ±15.8%
Management gave no formal guidance against steady demand and contracting margins. The delivery was rich in specifics.
Demand: stableMargins: contractingPricing: under pressure 2 analysts · 5 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growingFounder-led
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C
Q4 2023 earnings call
2023-12-15
move ±14.5%
Management gave no formal guidance against mixed demand signals. The delivery was unusually candid.
Demand: mixedMargins: stablePricing: raising 3 analysts · 10 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growingHidden segment
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C
Q3 2023 earnings call
2023-09-08
move ±15.4%
Management gave no formal guidance against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.
Demand: stableMargins: expandingPricing: stableHeadcount: growingCapex: increasing 3 analysts · 6 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubtsFounder-led
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q2 2023 |
2023-06-13 |
C+ |
maintained | stable | contracting |
7/9 |
2/9 |
| Q1 2023 |
2023-03-10 |
C |
none | stable | contracting |
7/9 |
4/9 |
| Q4 2022 |
2022-12-16 |
C |
none | mixed | contracting |
7/9 |
3/9 |
| Q3 2022 |
2022-09-09 |
B |
none | mixed | contracting |
8/9 |
2/9 |
| Q2 2022 |
2022-06-08 |
B |
none | mixed | contracting |
7/9 |
2/9 |
| Q1 2022 |
2022-03-04 |
D |
none | mixed | stable |
6/9 |
5/9 |
| Q4 2021 |
2021-12-17 |
C+ |
none | mixed | stable |
7/9 |
2/9 |
| Q3 2021 |
2021-09-10 |
B |
none | mixed | stable |
7/9 |
3/9 |
| Q2 2021 |
2021-06-11 |
C+ |
none | mixed | stable |
7/9 |
2/9 |
| Q1 2021 |
2021-03-12 |
B+ |
none | mixed | expanding |
7/9 |
2/9 |
| Q3 2020 |
2020-09-11 |
B+ |
none | mixed | stable |
7/9 |
2/9 |
| Q2 2020 |
2020-06-05 |
D |
none | mixed | expanding |
7/9 |
7/9 |
| Q1 2020 |
2020-03-06 |
B |
none | stable | expanding |
6/9 |
3/9 |
| Q4 2019 |
2019-12-13 |
B+ |
maintained | stable | expanding |
7/9 |
2/9 |
| Q3 2019 |
2019-09-13 |
C+ |
maintained | stable | contracting |
7/9 |
2/9 |
| Q2 2019 |
2019-06-07 |
D |
maintained | stable | stable |
6/9 |
4/9 |
| Q1 2019 |
2019-03-08 |
C |
none | mixed | stable |
7/9 |
2/9 |
| Q4 2018 |
2018-12-14 |
C |
none | stable | expanding |
6/9 |
4/9 |
| Q3 2018 |
2018-09-07 |
C+ |
none | stable | expanding |
6/9 |
3/9 |
| Q2 2018 |
2018-06-08 |
C+ |
none | mixed | expanding |
7/9 |
2/9 |
| Q1 2018 |
2018-03-09 |
C+ |
maintained | stable | expanding |
7/9 |
2/9 |
| Q3 2017 |
2017-09-08 |
B |
none | stable | stable |
8/9 |
2/9 |
| Q2 2017 |
2017-06-09 |
C |
none | stable | expanding |
7/9 |
4/9 |
| Q1 2017 |
2017-03-10 |
C+ |
maintained | stable | expanding |
7/9 |
3/9 |
| Q4 2016 |
2016-12-16 |
B+ |
maintained | stable | expanding |
7/9 |
2/9 |
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← EGFHF All “E” companies
EGHT →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.